HARNESSING SENESCENCE FOR HUMAN HEALTHSPAN
Atropos aims to treat aging-related diseases and cancer and improve healthspan with approved novel senescence- targeting drugs.
Atropos, the Fate whose duty it was
to cut the threads of life.
Robert S. Holzman, MD
The Legacy of Atropos, the Fate Who Cut the Thread of Life, 1998
June 11, 2020
Initial round of high throughput screening with Scripps Research Institute is completed and senosuppressor hits are currently being evaluated at Atropos.